quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:07:30·65d
SECFiling
Sana Biotechnology Inc. logo

Sana Biotechnology Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

SANA· Sana Biotechnology Inc.
Health Care
Original source

Companies

  • SANA
    Sana Biotechnology Inc.
    Health Care

Recent analyst ratings

  • Sep 24UpdateWedbush$5.00
  • Jul 3UpdateMorgan Stanley$12.00
  • Mar 18UpdateCitizens JMP$5.00
  • Mar 14UpdateJefferies$7.00
  • Jan 8UpdateTD Cowen-
  • Nov 5UpdateJMP Securities-

Related

  • SEC10d
    SEC Form 424B5 filed by Sana Biotechnology Inc.
  • SEC10d
    Sana Biotechnology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR10d
    Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
  • INSIDER15d
    SEC Form 4 filed by Bishop Hans Edgar
  • PR17d
    Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines
  • INSIDER27d
    SEC Form 3 filed by new insider Patel Dhavalkumar Dhirajlal
  • INSIDER44d
    President & CEO Harr Steve covered exercise/tax liability with 24,345 shares and converted options into 91,666 shares, increasing direct ownership by 0.85% to 7,944,251 units (SEC Form 4)
  • INSIDER44d
    Officer Wyrick Susan D. converted options into 13,666 shares and covered exercise/tax liability with 4,387 shares, increasing direct ownership by 5% to 196,196 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022